Back
Ovid Therapeutics Stock Price Chart
Sponsored
OVID
Sponsored
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Buy
63
OVID
Ovid Therapeutics
Last Price:
1.19
Seasonality Move:
-0.69%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret Loophole- The current trend is moderately bearish and OVID is experiencing slight buying pressure.
Ovid Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.27 | Sell |
20-day SMA: | 1.22 | Buy |
50-day SMA: | 1.16 | Buy |
200-day SMA: | 2.11 | Sell |
8-day EMA: | 1.26 | Sell |
20-day EMA: | 1.22 | Buy |
50-day EMA: | 1.2 | Buy |
200-day EMA: | 1.85 | Sell |
Ovid Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 52 | Buy |
Chaikin Money Flow: | 168484 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.14 - 1.26) | Buy |
Bollinger Bands (100): | (0.92 - 1.22) | Buy |
Ovid Therapeutics Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Ovid Therapeutics Stock
Is Ovid Therapeutics Stock a Buy?
- Ovid Therapeutics share price is 1.23 while OVID 8-day simple moving average is 1.27, which is a Sell signal.
- The stock price of OVID is 1.23 while Ovid Therapeutics 20-day SMA is 1.22, which makes it a Buy.
- Ovid Therapeutics 50-day simple moving average is 1.16 while OVID share price is 1.23, making it a Buy technically.
- OVID stock price is 1.23 and Ovid Therapeutics 200-day simple moving average is 2.11, creating a Sell signal.
OVID Technical Analysis vs Fundamental Analysis
Buy
63
Ovid Therapeutics (OVID)
is a Buy
Is Ovid Therapeutics a Buy or a Sell?
-
Ovid Therapeutics stock is rated a Buy
The current Ovid Therapeutics [OVID] share price is $1.23. The Score for OVID is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
Ovid Therapeutics Stock Info
Market Cap:
86.94M
Price in USD:
1.23
Share Volume:
385.11K
Ovid Therapeutics 52-Week Range
52-Week High:
4.10
52-Week Low:
0.68
Buy
63
Ovid Therapeutics (OVID)
is a Buy
Ovid Therapeutics Share Price Forecast
-
What is the Ovid Therapeutics stock price today?
The Ovid Therapeutics stock price is 1.23 USD today. -
Will OVID stock go up or go down?
Ovid Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Ovid Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ovid Therapeutics is not overvalued.
Is Ovid Therapeutics Stock a Buy?
- Ovid Therapeutics share price is 1.23 while OVID 8-day exponential moving average is 1.26, which is a Sell signal.
- The stock price of OVID is 1.23 while Ovid Therapeutics 20-day EMA is 1.22, which makes it a Buy.
- Ovid Therapeutics 50-day exponential moving average is 1.20 while OVID share price is 1.23, making it a Buy technically.
- OVID stock price is 1.23 and Ovid Therapeutics 200-day simple moving average is 1.85, creating a Sell signal.
Fundamental Analysis of Ovid Therapeutics
Is Ovid Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.20 per share, and a decrease next year of $0.24 per share.
Technical Analysis of Ovid Therapeutics
Should I short Ovid Therapeutics stock?
- OVID Moving Average Covergence Divergence (MACD) indicator is 0.03, suggesting Ovid Therapeutics is a Buy
- Ovid Therapeutics Relative Strength Index (RSI) is 52, which suggest Ovid Therapeutics is overbought
- The Bollinger Bands (25) for Ovid Therapeutics is (1.14 - 1.26), which suggest Ovid Therapeutics is a Buy
- The Bollinger Bands (100) for Ovid Therapeutics is (0.92 - 1.22), which suggest Ovid Therapeutics is a Buy
* Ovid Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.